Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01051037 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01051037: Completed NA study, sponsored by Jonsson Comprehensive Cancer Center.
NCT01051037 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01051037, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that combined stereotactic body radiotherapy and radiofrequency ablation is safe for patients with lung tumors near central airways.
Interventions
- RADIATION Stereotactic Body Radiation
- RADIATION Radiofrequency Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-02-08 |
| Est. Completion | 2017-12-20 |
| Phase | NA |
What the finished NCT01051037 record still lists
NCT01051037 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Stereotactic Body Radiation is the first listed.
NCT01051037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01051037 about?
NCT01051037 is a clinical study titled "Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways". The purpose of this study is to demonstrate that combined stereotactic body radiotherapy and radiofrequency ablation is safe for patients with lung tumors near central airways.
What is the current status of trial NCT01051037?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2010-02-08. Estimated completion is 2017-12-20.
What interventions are being tested in trial NCT01051037?
The interventions under investigation include: Stereotactic Body Radiation (RADIATION), Radiofrequency Ablation (RADIATION).
Who is sponsoring clinical trial NCT01051037?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01051037's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI